Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Staging
67 results:
1. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract] [Full Text] [Related]
2. Combination of [
Kim J; Lee S; Kim D; Kim HJ; Oh KT; Kim SJ; Choi YD; Giesel FL; Kopka K; Hoepping A; Lee M; Yun M
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1763-1772. PubMed ID: 38200396
[TBL] [Abstract] [Full Text] [Related]
3. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
Jia G; Dong A; Cheng C; Zuo C
Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
[TBL] [Abstract] [Full Text] [Related]
4. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
[TBL] [Abstract] [Full Text] [Related]
5. Impact of uptake time on image quality of [
van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B
Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883
[TBL] [Abstract] [Full Text] [Related]
6. The roles of 68 Ga-PSMA PET/CT and 18 F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
Arslan E; Ergül N; Beyhan E; Erol Fenercioglu Ö; Sahin R; Cin M; Battal Havare S; Can Trabulus FD; Mermut Ö; Akbas S; Fikret Çermik T
Nucl Med Commun; 2023 Apr; 44(4):284-290. PubMed ID: 36756767
[TBL] [Abstract] [Full Text] [Related]
7. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
8. [The intensity of PSMA intraprostatic uptake as a predictor of clinically significant prostate cancer].
Bergero MA; Costa L; Modina P; Carlos D; Arceluz MJ; Faccio FF
Medicina (B Aires); 2022; 82(6):845-850. PubMed ID: 36571522
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of 18 F-PSMA-1007 PET/CT With 68 Ga-PSMA-11 PET/CT for Initial staging in Intermediate- and High-Risk prostate cancer.
Chandekar KR; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
Clin Nucl Med; 2023 Jan; 48(1):e1-e8. PubMed ID: 36240786
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of
Schollhammer R; Robert G; Asselineau J; Yacoub M; Vimont D; Balamoutoff N; Bladou F; Bénard A; Hindié E; Gallerande HC; Morgat C
J Nucl Med; 2023 Mar; 64(3):379-385. PubMed ID: 36215569
[TBL] [Abstract] [Full Text] [Related]
11. Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.
Li Y; Zheng R; Zhang Y; Huang C; Tian L; Liu R; Liu Y; Zhang Z; Han H; Zhou F; He L; Dong P
Int J Cancer; 2023 Jan; 152(1):42-50. PubMed ID: 35751420
[TBL] [Abstract] [Full Text] [Related]
12. Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging.
Li Y; Duan X; Xu H; Zhang J; Zhou H; Zhang X; Zhang J; Yang Z; Hu Z; Zhang N; Tian J; Yang X
Bioorg Med Chem; 2022 Jul; 66():116810. PubMed ID: 35580538
[TBL] [Abstract] [Full Text] [Related]
13. Bone Uptake in prostate cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68 Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence.
Letang A; Crombé A; Rousseau C; Sargos P; Merlin C; Cantarel C; Cazeau AL
Clin Nucl Med; 2022 Aug; 47(8):e529-e539. PubMed ID: 35543633
[TBL] [Abstract] [Full Text] [Related]
14.
Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
[TBL] [Abstract] [Full Text] [Related]
15. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI.
Laudicella R; Rüschoff JH; Ferraro DA; Brada MD; Hausmann D; Mebert I; Maurer A; Hermanns T; Eberli D; Rupp NJ; Burger IA
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3917-3928. PubMed ID: 35435496
[TBL] [Abstract] [Full Text] [Related]
16. Hot needles can confirm accurate lesion sampling intraoperatively using [
Ferraro DA; Laudicella R; Zeimpekis K; Mebert I; Müller J; Maurer A; Grünig H; Donati O; Sapienza MT; Rueschoff JH; Rupp N; Eberli D; Burger IA
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1721-1730. PubMed ID: 34725726
[TBL] [Abstract] [Full Text] [Related]
17. Artificial intelligence-based measurements of PET/CT imaging biomarkers are associated with disease-specific survival of high-risk prostate cancer patients.
Polymeri E; Kjölhede H; Enqvist O; Ulén J; Poulsen MH; Simonsen JA; Borrelli P; Trägårdh E; Johnsson ÅA; Høilund-Carlsen PF; Edenbrandt L
Scand J Urol; 2021 Dec; 55(6):427-433. PubMed ID: 34565290
[TBL] [Abstract] [Full Text] [Related]
18. Detection of Additional Primary Neoplasms on
Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
[TBL] [Abstract] [Full Text] [Related]
19. What's behind
Rüschoff JH; Ferraro DA; Muehlematter UJ; Laudicella R; Hermanns T; Rodewald AK; Moch H; Eberli D; Burger IA; Rupp NJ
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4042-4053. PubMed ID: 34386839
[TBL] [Abstract] [Full Text] [Related]
20. Focal unspecific bone uptake on [
Grünig H; Maurer A; Thali Y; Kovacs Z; Strobel K; Burger IA; Müller J
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4483-4494. PubMed ID: 34120201
[TBL] [Abstract] [Full Text] [Related]
[Next]